These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 37550764)

  • 1. GATA2 co-opts TGFβ1/SMAD4 oncogenic signaling and inherited variants at 6q22 to modulate prostate cancer progression.
    Yang X; Zhang Q; Li S; Devarajan R; Luo B; Tan Z; Wang Z; Giannareas N; Wenta T; Ma W; Li Y; Yang Y; Manninen A; Wu S; Wei GH
    J Exp Clin Cancer Res; 2023 Aug; 42(1):198. PubMed ID: 37550764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Inherited Allele Confers Prostate Cancer Progression and Drug Resistance via RFX6/HOXA10-Orchestrated TGFβ Signaling.
    Zhong M; Xu W; Tian P; Zhang Q; Wang Z; Liang L; Zhang Q; Yang Y; Lu Y; Wei GH
    Adv Sci (Weinh); 2024 Aug; 11(32):e2401492. PubMed ID: 38932472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SMAD4-dependent barrier constrains prostate cancer growth and metastatic progression.
    Ding Z; Wu CJ; Chu GC; Xiao Y; Ho D; Zhang J; Perry SR; Labrot ES; Wu X; Lis R; Hoshida Y; Hiller D; Hu B; Jiang S; Zheng H; Stegh AH; Scott KL; Signoretti S; Bardeesy N; Wang YA; Hill DE; Golub TR; Stampfer MJ; Wong WH; Loda M; Mucci L; Chin L; DePinho RA
    Nature; 2011 Feb; 470(7333):269-73. PubMed ID: 21289624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prostate cancer susceptibility allele at 6q22 increases RFX6 expression by modulating HOXB13 chromatin binding.
    Huang Q; Whitington T; Gao P; Lindberg JF; Yang Y; Sun J; Väisänen MR; Szulkin R; Annala M; Yan J; Egevad LA; Zhang K; Lin R; Jolma A; Nykter M; Manninen A; Wiklund F; Vaarala MH; Visakorpi T; Xu J; Taipale J; Wei GH
    Nat Genet; 2014 Feb; 46(2):126-35. PubMed ID: 24390282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-539 functions as a tumour suppressor in prostate cancer via the TGF-β/Smad4 signalling pathway by down-regulating DLX1.
    Sun B; Fan Y; Yang A; Liang L; Cao J
    J Cell Mol Med; 2019 Sep; 23(9):5934-5948. PubMed ID: 31298493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Androgen receptor transcriptionally regulates semaphorin 3C in a GATA2-dependent manner.
    Tam KJ; Dalal K; Hsing M; Cheng CW; Khosravi S; Yenki P; Tse C; Peacock JW; Sharma A; Chiang YT; Wang Y; Cherkasov A; Rennie PS; Gleave ME; Ong CJ
    Oncotarget; 2017 Feb; 8(6):9617-9633. PubMed ID: 28038451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A COP1-GATA2 axis suppresses AR signaling and prostate cancer.
    Shen T; Dong B; Meng Y; Moore DD; Yang F
    Proc Natl Acad Sci U S A; 2022 Oct; 119(43):e2205350119. PubMed ID: 36251994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ChIP-seq defined genome-wide map of TGFβ/SMAD4 targets: implications with clinical outcome of ovarian cancer.
    Kennedy BA; Deatherage DE; Gu F; Tang B; Chan MW; Nephew KP; Huang TH; Jin VX
    PLoS One; 2011; 6(7):e22606. PubMed ID: 21799915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A network including TGFβ/Smad4, Gata2, and p57 regulates proliferation of mouse hematopoietic progenitor cells.
    Billing M; Rörby E; May G; Tipping AJ; Soneji S; Brown J; Salminen M; Karlsson G; Enver T; Karlsson S
    Exp Hematol; 2016 May; 44(5):399-409.e5. PubMed ID: 26876150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cooperative Regulation of the Mucosal Mast Cell-Specific Protease Genes
    Kasakura K; Nagata K; Miura R; Iida M; Nakaya H; Okada H; Arai T; Arai T; Kawakami Y; Kawakami T; Yashiro T; Nishiyama C
    J Immunol; 2020 Mar; 204(6):1641-1649. PubMed ID: 32005755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Copy number gain of ZEB1 mediates a double-negative feedback loop with miR-33a-5p that regulates EMT and bone metastasis of prostate cancer dependent on TGF-β signaling.
    Dai Y; Wu Z; Lang C; Zhang X; He S; Yang Q; Guo W; Lai Y; Du H; Peng X; Ren D
    Theranostics; 2019; 9(21):6063-6079. PubMed ID: 31534537
    [No Abstract]   [Full Text] [Related]  

  • 12. CCAR1 promotes chromatin loading of androgen receptor (AR) transcription complex by stabilizing the association between AR and GATA2.
    Seo WY; Jeong BC; Yu EJ; Kim HJ; Kim SH; Lim JE; Kwon GY; Lee HM; Kim JH
    Nucleic Acids Res; 2013 Oct; 41(18):8526-36. PubMed ID: 23887938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MAZ promotes prostate cancer bone metastasis through transcriptionally activating the KRas-dependent RalGEFs pathway.
    Yang Q; Lang C; Wu Z; Dai Y; He S; Guo W; Huang S; Du H; Ren D; Peng X
    J Exp Clin Cancer Res; 2019 Sep; 38(1):391. PubMed ID: 31488180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of GATA2 in prostate cancer by a clinically available small molecule.
    Kaochar S; Rusin A; Foley C; Rajapakshe K; Robertson M; Skapura D; Mason C; Berman De Ruiz K; Tyryshkin AM; Deng J; Shin JN; Fiskus W; Dong J; Huang S; Navone NM; Davis CM; Ehli EA; Coarfa C; Mitsiades N
    Endocr Relat Cancer; 2021 Nov; 29(1):15-31. PubMed ID: 34636746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of miR‑19a‑3p promotes invasion, migration and bone metastasis via activating TGF‑β signaling in prostate cancer.
    Wa Q; Li L; Lin H; Peng X; Ren D; Huang Y; He P; Huang S
    Oncol Rep; 2018 Jan; 39(1):81-90. PubMed ID: 29138858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three-tiered role of the pioneer factor GATA2 in promoting androgen-dependent gene expression in prostate cancer.
    Wu D; Sunkel B; Chen Z; Liu X; Ye Z; Li Q; Grenade C; Ke J; Zhang C; Chen H; Nephew KP; Huang TH; Liu Z; Jin VX; Wang Q
    Nucleic Acids Res; 2014 Apr; 42(6):3607-22. PubMed ID: 24423874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transforming Growth Factor β1/Smad4 Signaling Affects Osteoclast Differentiation via Regulation of miR-155 Expression.
    Zhao H; Zhang J; Shao H; Liu J; Jin M; Chen J; Huang Y
    Mol Cells; 2017 Mar; 40(3):211-221. PubMed ID: 28359146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Androgen receptor and TGFbeta1/Smad signaling are mutually inhibitory in prostate cancer.
    van der Poel HG
    Eur Urol; 2005 Dec; 48(6):1051-8. PubMed ID: 16257107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GATA-2 inhibits transforming growth factor-β signaling pathway through interaction with Smad4.
    Dong XM; Yin RH; Yang Y; Feng ZW; Ning HM; Dong L; Zheng WW; Tang LJ; Wang J; Jia YX; Jiang YN; Liu ED; Chen H; Zhan YQ; Yu M; Ge CH; Li CY; Yang XM
    Cell Signal; 2014 May; 26(5):1089-97. PubMed ID: 24509415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COUP-TFII inhibits TGF-β-induced growth barrier to promote prostate tumorigenesis.
    Qin J; Wu SP; Creighton CJ; Dai F; Xie X; Cheng CM; Frolov A; Ayala G; Lin X; Feng XH; Ittmann MM; Tsai SJ; Tsai MJ; Tsai SY
    Nature; 2013 Jan; 493(7431):236-40. PubMed ID: 23201680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.